Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Skip More from NICE submenu
Explore more from NICE
What NICE does
About us
Reusing our content
Implementing NICE guidance
News, blogs and podcasts
Contact us
Get involved
Careers
Join a committee
Comment on a consultation
Close menu
My account
Consultation responses
Sign in
Home
NICE Guidance
Conditions and diseases
Cancer
Lung cancer
Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer
Technology appraisal guidance [TA411]
Published:
28 September 2016
Guidance
Tools and resources
Information for the public
Evidence
History
Do no do examples
Do no do examples for Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer
Title
Year published
Impact Level
No results could be found